Published in Dermatology on September 14, 2013
Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med (2015) 1.18
Bilateral Choroidopathy and Serous Retinal Detachments During Ipilimumab Treatment for Cutaneous Melanoma. JAMA Ophthalmol (2015) 0.81
New clinical advances in immunotherapy for the treatment of solid tumours. Immunology (2015) 0.76
Acute visual loss after ipilimumab treatment for metastatic melanoma. J Immunother Cancer (2016) 0.75
Targeted Lung Cancer Treatments and Eye Metastasis. Med Hypothesis Discov Innov Ophthalmol (2017) 0.75
Melanoma associated retinopathy: A new dimension using adaptive optics. Oman J Ophthalmol (2015) 0.75
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet (1998) 3.77
Umbilical metastasis or Sister Mary Joseph's nodule. Int J Dermatol (1998) 2.44
Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34
[Survey of post-graduate training for Dermatology and Venereology residents in France (2005-2010)]. Ann Dermatol Venereol (2013) 2.00
A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol (2006) 1.78
Induction of toll-like receptors by Propionibacterium acnes. Br J Dermatol (2005) 1.54
Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy. Neurology (2003) 1.50
[Descriptive epidemiological study of acne on scholar pupils in France during autumn 1996]. Ann Dermatol Venereol (2000) 1.43
Tumour of the juxtaoral organ. Int J Oral Maxillofac Surg (2003) 1.41
Hepatocellular adenomatosis presenting as prurigo. Br J Dermatol (2000) 1.40
[Acne scars: epidemiology, physiopathology, clinical features and treatment]. Ann Dermatol Venereol (2006) 1.40
Expression pattern, genomic structure and evaluation of the human SLC30A4 gene as a candidate for acrodermatitis enteropathica. Hum Genet (2001) 1.40
[Neutrophilic eccrine hidradenitis in a healthy patient]. Ann Dermatol Venereol (2005) 1.37
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol (2009) 1.32
Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. J Med Genet (2005) 1.30
Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29
Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol (2005) 1.24
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol (2005) 1.19
An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol (2001) 1.17
Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients. Ann Rheum Dis (2008) 1.08
Interstitial granulomatous dermatitis with cutaneous cords and arthritis: a disorder associated with autoantibodies. J Am Acad Dermatol (2001) 1.02
Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole. Dermatologica (1989) 1.01
Modulatory effects of selenium and strontium salts on keratinocyte-derived inflammatory cytokines. Arch Dermatol Res (1995) 1.00
Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (2000) 0.98
Female acne - a different subtype of teenager acne? J Eur Acad Dermatol Venereol (2011) 0.97
Immunotherapy of distant metastatic disease. Ann Oncol (2009) 0.96
[Orofacial manifestations of systemic sclerosis: A study of 30 consecutive patients]. Rev Stomatol Chir Maxillofac (2010) 0.95
Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology (2004) 0.95
Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation. Am J Transplant (2011) 0.94
[Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients]. Rev Med Interne (2008) 0.94
Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol (2013) 0.94
Hepatosplenic gamma/delta T-cell lymphoma: a report of two cases in immunocompromised patients, associated with isochromosome 7q. Am J Surg Pathol (1997) 0.94
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92
Chemical peels in aesthetic dermatology: an update 2009. J Eur Acad Dermatol Venereol (2009) 0.91
Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials. J Am Acad Dermatol (1997) 0.91
Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther (2014) 0.91
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription. J Immunol (1997) 0.91
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy. J Immunother (1991) (1991) 0.90
[Localized bullous pemphigoid following radiotherapy]. Ann Dermatol Venereol (2000) 0.90
Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients. Int J Dermatol (1990) 0.90
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells. Clin Cancer Res (2000) 0.89
Drug-induced acute generalized exanthematous pustulosis with positive patch tests. Int J Dermatol (1995) 0.89
Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris. Br J Dermatol (1995) 0.89
External radiation exposure and mortality in a cohort of French nuclear workers. Occup Environ Med (2007) 0.88
Hypersensitivity syndrome due to 2 anticonvulsant drugs. Contact Dermatitis (1999) 0.88
Phototoxic and photoprotective effects of topical isothipendyl. Photodermatol Photoimmunol Photomed (1995) 0.87
Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies. Autoimmun Rev (2013) 0.87
White blood cell count: a prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma. Clin Cancer Res (2000) 0.87
[Psoriatic onycho-pachydermo-periostitis]. Ann Dermatol Venereol (1993) 0.86
[An association of paraneoplastic syndromes in a patient]. Ann Dermatol Venereol (2002) 0.86
Loss of oncostatin M receptor beta in metastatic melanoma cells. Oncogene (2006) 0.86
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
[Melanoma in organ transplant patients]. Ann Dermatol Venereol (2000) 0.85
Control of growth and differentiation of normal human epithelial cells through the manipulation of reactive nitrogen species. Biochem J (1998) 0.84
Is Vacuum Assisted Closure a valid technique for debriding chronic leg ulcers? J Wound Care (2004) 0.84
Recurrent cuniculatum squamous cell carcinoma of the fingers and virus. J Eur Acad Dermatol Venereol (2008) 0.84
Cancer mortality among French Atomic Energy Commission workers. Am J Ind Med (2004) 0.83
The hypothetical role of FoxO1 in acne is interesting, but more study is needed before any conclusions can be drawn. Br J Dermatol (2010) 0.83
Evaluation of the chemical model of vestibular lesions induced by arsanilate in rats. Toxicol Appl Pharmacol (2011) 0.83
Polyomavirus-induced acute tubulo-interstitial nephritis in renal allograft recipients. Transplant Proc (2000) 0.83
Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma. Eur J Cancer (2001) 0.83
A new sclerosing agent in the treatment of venous malformations. Study on 23 cases. Interv Neuroradiol (2004) 0.81
Zinc, copper and manganese enhanced keratinocyte migration through a functional modulation of keratinocyte integrins. Exp Dermatol (2000) 0.81
[Paraneoplastic multicentric reticulohistiocytosis]. Ann Dermatol Venereol (2011) 0.81
HLA class II-restricted recognition of common tumor epitopes on human melanoma cells by CD4+ melanoma-infiltrating lymphocytes. Eur J Immunol (1995) 0.81
[Rhinophyma. The value of progressive dermabrasion]. Rev Stomatol Chir Maxillofac (1991) 0.81
Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up. Br J Dermatol (2010) 0.81
Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients. J Thromb Haemost (2004) 0.81
[A rare association: rheumatoid arthritis and the yellow nail syndrome. Report of 2 cases]. Rev Rhum Mal Osteoartic (1981) 0.80
Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins. Clin Exp Rheumatol (2008) 0.80
[CO2 laser therapy of verrucous epidermal nevus]. Ann Dermatol Venereol (2006) 0.80
Epidemiological response to a suspected excess of cancer among a group of workers exposed to multiple radiological and chemical hazards. Occup Environ Med (2000) 0.80
Presence of Epstein-Barr virus in Langerhans cells of CTCL lesions. J Invest Dermatol (2005) 0.80
Genotypes and phenotypes of 162 families with a glomulin mutation. Mol Syndromol (2013) 0.80
Recurring postoperative pyoderma gangrenosum. Int J Dermatol (1995) 0.80
Skin reactions to hydroxyzine. Contact Dermatitis (1997) 0.80
Classification of acne scars is difficult even for acne experts. J Eur Acad Dermatol Venereol (2012) 0.80
Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report. Case Rep Med (2010) 0.79
Pulmonary embolism and deep jugular venous thrombosis resulting from compression by a lipoma. Dermatol Online J (2006) 0.79
[Cutaneous and neurologic vasculitis disclosing EBV-selective immunodeficiency]. Ann Dermatol Venereol (1996) 0.79
[Primitive renal neuroectodermal tumor (PNET). Apropos of a case]. Prog Urol (1998) 0.79
[The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne]. Ann Dermatol Venereol (1998) 0.79
Cutaneous malacoplakia. Int J Dermatol (1994) 0.79
Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Eur J Dermatol (2007) 0.79
Endothelial cell apoptosis in severe drug-induced bullous eruptions. Br J Dermatol (2009) 0.79
[Angiomatoid fibrous histiocytoma: a rare pathologic entity]. Ann Pathol (2001) 0.79
[Description of erlotinib-related skin effects management in France. Results of the PRECEDE study]. Cancer Radiother (2009) 0.78
Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes. Int J Cancer (1998) 0.78
Spectrum of CD30 lymphoproliferative diseases from lymphomatoid papulosis to anaplastic large cell lymphoma. Int J Dermatol (1996) 0.78
[Infantile bullous pemphigoid]. Ann Dermatol Venereol (2012) 0.78
Pustular contact dermatitis from fluorine in an antirust solution. Contact Dermatitis (1997) 0.78
Low-dose recombinant interferon-alpha in the treatment of cutaneous T-cell lymphomas. Br J Dermatol (1989) 0.78
Long-term interferon-alpha therapy induces autoantibodies against epidermis. Dermatology (1996) 0.78
[Head and neck desmoid tumor in children: a case report and review of the literature]. Ann Otolaryngol Chir Cervicofac (2000) 0.78